United Therapeutics buy StockNews.com
Start price
16.07.24
/
50%
€302.30
Target price
16.07.25
-
Performance (%)
-15.81%
End price
17.07.25
€254.50
Summary
This prediction ended on 17.07.25 with a price of €254.50. The price of United Therapeutics has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -15.81%. StockNews_com has a follow-up prediction for United Therapeutics where he still thinks United Therapeutics is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| United Therapeutics | -0.177% | -0.177% | 16.992% |
| iShares Core DAX® | -1.432% | 0.000% | 12.331% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.688% |
| iShares Nikkei 225® | 1.448% | 5.269% | 18.051% |
| iShares S&P 500 | 0.114% | -0.217% | 1.388% |
Comments by StockNews_com for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics Co. (NASDAQ: UTHR) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for UTHR provided by MarketBeat
In the thread Trading United Therapeutics
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten